| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |